Pharma Resources (Shanghai) Co (SZSE:301230) EV-to-Revenue : 6.10 (As of Jun. 17, 2024)

Pharma Resources (Shanghai) Co EV-to-Revenue Chart

Pharma Resources (Shanghai) Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															8.64	8.62	9.09	7.18	8.28

Competitive Comparison of Pharma Resources (Shanghai) Co's EV-to-Revenue

For the Biotechnology subindustry, Pharma Resources (Shanghai) Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Resources (Shanghai) Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Resources (Shanghai) Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharma Resources (Shanghai) Co's EV-to-Revenue falls into.

Pharma Resources (Shanghai) Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pharma Resources (Shanghai) Co's EV-to-Revenue for today is calculated as:

Pharma Resources (Shanghai) Co's current Enterprise Value is ¥3,043.6 Mil.
Pharma Resources (Shanghai) Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥499.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Resources (Shanghai) Co  (SZSE:301230) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pharma Resources (Shanghai) Co's PS Ratiofor today is calculated as:

Pharma Resources (Shanghai) Co's share price for today is ¥30.66.
Pharma Resources (Shanghai) Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.51.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Resources (Shanghai) Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharma Resources (Shanghai) Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Resources (Shanghai) Co (SZSE:301230) Business Description